News

SWK Holdings Corporation Announces 2016 Third Quarter Financial Results

  • Total revenues of $4.2 million for the third quarter of 2016 compared to $5.7 million for the third quarter of 2015
  • For the third quarter of 2016 net income attributable to SWK Shareholders of $3.1 million, or $0.24 per share, and non-GAAP adjusted net income of $2.6 million, or $0.20 per share
  • For the first-nine months of 2016 net income attributable to SWK Shareholders of $5.2 million, or $0.39 per share, and non-GAAP adjusted net income of $4.2 million, or $0.32 per share
  • Total income producing assets (defined as finance receivables, marketable investments and investment in unconsolidated entities less non-controlling interests) were $95.3 million as of September 30, 2016
  • Book value of $13.74 per share as of September 30, 2016
  • $66.4 million of cash available for deployment
  • YTD through November 8, closed four new financings deploying $31.4 million at a weighted average 15.5% GAAP projected effective yield
  • After quarter close, one SWK partner signed agreement to be acquired; YTD three SWK partners have been acquired by strategic buyers

Dallas, TX, November 8, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2016 financial results.

– Read More –

SWK Holdings Corporation Announces 2016 Second Quarter Financial Results

  • Total revenues of $8.6 million for the three months ended June 2016 compared to $5.4 million for the second quarter of 2015
  • For the three months ended June 2016 net loss attributable to SWK Shareholders of $1.0 million, or $0.08 per share, and non-GAAP adjusted net loss of $0.6 million, or $0.04 per share
  • For the six months ended June 2016 net income attributable to SWK Shareholders of $2.1 million, or $0.16 per share, and non-GAAP adjusted net income of $2.5 million, or $0.19 per share
  • Total income producing assets (defined as finance receivables, marketable securities and investment in unconsolidated subsidiaries less non-controlling interests) were $81.9 million as of June 30, 2016
  • Book value of $13.62 per share as of June 30, 2016
  • $76.6 million of cash available for deployment
  • YTD through August 10, closed four new financings deploying $32.0 million at a weighted average 15.5% GAAP projected effective yield
  • For the three months ended June 2016 two SWK partners were acquired by strategic buyers; YTD three SWK partners have been acquired by strategic buyers
  • Exited SynCardia debt and equity positions for a $7.2 million cash payment plus additional certain future contingent payments

Dallas, TX, August 10, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2016 financial results.

– Read More –

SWK Holdings Corporation Announces 2016 First Quarter Financial Results

  • Total revenues of approximately $5.2 million for the first quarter of 2016.
  • Net income attributable to SWK Shareholders of $3.1 million, or $0.24 per share, and non-GAAP Adjusted net income of $3.1 million, or $0.24 per share.
  • Book value of $13.71 per share as of March 31, 2016.

Dallas, TX, May 13, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2016 financial results.

– Read More –

SWK Holdings Corporation Announces 2015 Fourth Quarter and Full-Year Financial Results

  • Total revenues increased by 35% to approximately $23.5 million for the fiscal year of 2015, compared to $17.4 million for the fiscal year of 2014
  • Recorded a net loss attributable to SWK stockholders of $7.4 million, or $(0.57) per share, for the fiscal year of 2015, compared to net income attributable to SWK stockholders of $20.8 million, or $3.20 per share, for the fiscal year of 2014
  • Net cash provided by operating activities increased by 119% to approximately $11.2 million, or $0.86 per share, for the fiscal year of 2015, compared to $5.1 million, or $0.79 per share, for the fiscal year of 2014
  • Recorded aggregate provisions for loan credit loss and security impairment expense of $17.5 million related primarily to SynCardia Systems and Response Genetics positions
  • Non-GAAP Adjusted net loss of $1.4 million, or $(0.11) per share, for the fiscal year of 2015, compared Non-GAAP Adjusted net income of $10.7 million, or $1.65 per share, for the fiscal year of 2014
  • Book value of $13.47 per share as of December 31, 2015

Dallas, TX, March 23, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today its fourth quarter and full year 2015 financial results.

– Read More –

SWK Holdings Corporation Announces 2015 Third Quarter Financial Results and Appointment of New CEO

  • Total revenues increased by 53% to approximately $5.7 million for the third quarter of 2015, compared to $3.7 million for the third quarter of 2014
  • Recorded a net loss attributable to SWK stockholders of $5.8 million, or ($0.44) per share for the third quarter of 2015, compared to net income attributable to SWK stockholders of $0.4 million, or $0.06 per share for the third quarter of 2014
  • Recorded $8.1 million provision for credit losses related to Response Genetics and SynCardia Systems term loans
  • Non-GAAP Adjusted net loss of $6.9 million, or ($0.53) per share, for the third quarter of 2015, compared Non-GAAP Adjusted net income of $1.5 million, or $0.22 per share, for the third quarter of 2014
  • Executed a 1-for-100 reverse stock split of the common stock, followed by a 10-for-1 forward stock split of the common stock
  • Book value of $1.60 per share
  • Brett Pope, Chief Executive Officer, will resign effective January 12, 2016, to pursue other interests. Winston Black, currently Managing Director of SWK, will succeed Mr. Pope as Chief Executive Officer.

Dallas, TX, November 16, 2015 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today its third quarter 2015 financial results.

– Read More –

SWK Holdings Corporation Clarifies Timing of Post Split Trading

Dallas, TX –– 9/16/15 – SWK Holdings Corporation (OTCQB: SWKH) (“SWK” or the “Company”), a life science focused specialty finance company, announced a clarification on the timing of the trading of the Company’s common stock on a post-split basis following the execution of the previously announced stock splits effective as of 5:00 p.m. on September 15, 2015.

– Read More –

SWK Holdings Corporation Announces Timing of Stock Split

Dallas, TX – 08/28/15 – SWK Holdings Corporation (OTCQB: SWKH) (“SWK” or the “Company”), a life science focused specialty finance company, today announced a 1-for-100 reverse stock split of its common stock, immediately followed by a 10-for-1 forward stock split of its common stock. The stock splits will be effective as of 5:00 pm Eastern Time September 15, 2015. Beginning with the opening of trading on September 16, 2015, the Company’s common stock will trade on OTCQB on a post-split basis. The stock split was approved at SWK’s 2015 Annual Meeting of Stockholders held on May 20, 2015.

– Read More –

SWK Holdings Corporation Announces 2015 Second Quarter Financial Results

  • Total revenues increased by 61% to approximately $5.4 million for the second quarter of 2015, compared to $3.4 million for the second quarter of 2014
  • Recorded a net loss attributable to SWK stockholders of $0.4 million, or ($0.00) per share for the second quarter of 2015, compared to net income attributable to SWK stockholders of $1.4 million, or $0.03 per share for the second quarter of 2014
  • Recorded $2.6 million provision for credit losses related to Response Genetics term loan
  • Non-GAAP Adjusted net income decreased 78% to $0.4 million, or $0.00 per share for the second quarter of 2015, compared to $1.8 million, or $0.04 per share for the second quarter of 2014
  • Funded four new transactions totaling $30 million during the second quarter
  • Book value increased to $1.42 per share

Dallas, TX, August 14, 2015 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2015 financial results.

– Read More –

SWK Holdings Corporation Announces 2015 First Quarter Financial Results

  • Total revenues increased by 58% to approximately $5.8 million for the first quarter of 2015, compared to $3.7 million for the first quarter of 2014
  • Net income increased 55% to $2.3 million, or $0.02 per share for the first quarter of 2015, compared to $1.5 million, or $0.04 per share for the first quarter of 2014
  • Non-GAAP Adjusted net income increased 77% to $3.5 million, or $0.03 per share for the three months ending March 31, 2015, compared to. $2.0 million, or $0.05 per share for the first quarter of 2014.
  • Book value increased to $1.42 per share

Dallas, TX, May 11, 2015 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today its first quarter 2015 financial results.

– Read More –

SWK Holdings Corporation Announces 2014 Fourth Quarter and Full-Year Financial Results

  • Net income and adjusted net income to SWK stockholders of $20.8 million, or $0.32 per share, and $11.2 million, or $0.17 per share, respectively, for fiscal year 2014 vs. $12.9 million, or $0.31 per share, and $3.2 million, or $0.08 per share, respectively, for fiscal year 2013
  • Book value increased 20% in fiscal year 2014 over 2013 to $1.40 per diluted share
  • Funded transactions totaling $49.8 million during the fourth quarter, and an aggregate of $71.5 million during fiscal year 2014
  • Raised Approximately $113 Million in equity capital in 2014

Dallas, TX, March 30, 2015 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today its fourth quarter and full year 2014 financial results.

– Read More –

Older Posts